Business Brief -- Regeneron Pharmaceuticals Inc.:
   Lou Gehrig's Disease Drug
   Gets Orphan Drug Status
In over-the-counter trading yesterday afternoon, Regeneron
was quoted at $22.125, down 12.5 cents.